JOHN HEAD: Open Payments
NPI 1750393690 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,249 in 356 payments from 13 companies in 2025. Trend: 2023 $3,535 · 2024 $4,849 · 2025 $7,249
Food & beverage: $7,026Education: $223
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 94 | $1,550 |
| Neurocrine BioSciences, Inc. | 59 | $1,242 |
| Otsuka America Pharmaceutical, Inc. | 42 | $924 |
| ABBVIE INC. | 43 | $789 |
| Alkermes, Inc. | 26 | $658 |
| Axsome Therapeutics, Inc. | 22 | $449 |
| Lundbeck LLC | 18 | $394 |
| Teva Pharmaceuticals USA, Inc. | 4 | $367 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $280 |
| Indivior Inc. | 15 | $274 |
Products named: COBENFY, INGREZZA, REXULTI, VRAYLAR, ARISTADA, Auvelity, ABILIFY MAINTENA, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
